All Publications
Fact Sheets


Intro COPY

Learn More PDF

PATH/Gabe Bienczycki
WHO Roadmap for Access: 2019-2023

Provides analysis of the World Health Organization’s (WHO) draft Road Map for Access to Medicines, Vaccines and Other Health Products including an overview of the contents and the potential implications if approved. This roadmap, which outlines WHO’s proposed workplan on access for the period 2019–2023, will be presented to the WHO Executive Board in January 2018 for input and then will go before the World Health Assembly in May for endorsement.


Multilateralism for GHTC: Overview brief

Provides an overview of the opportunities and institutions GHTC targets in the multilateral arena, why GHTC advocates in that arena, and how our members and partners can participate in these opportunities.


Enhancing GHSA’s role in supporting global health R&D to advance health security

Provides background on the Global Health Security Agenda (GHSA) and limitations with its current structure, and offers recommendations to expand the comprehensiveness of the program in advancing global health security through the adoption of a new action package on global health R&D.


Return On Innovation: Learn how global health R&D delivers for your state

Interactive online tool and individualized state fact sheets documenting how US investments in global health R&D are delivering economic and health benefits across American states.


Bolstering BARDA’s role in combatting naturally occurring threats and emerging infectious diseases

Provides background on the mission of the Biomedical Advanced Research and Development Authority (BARDA), its engagement to date in combatting naturally occurring threats and emerging infectious diseases, and limitations that hinder its ability to sustain and increase activities in this space.


Pandemic and All-Hazards Preparedness Reauthorization Act priorities

Recommends actions to bolster BARDA’s role in developing medical countermeasures against naturally occurring threats and emerging infectious diseases through the 2018 reauthorization of the Pandemic and All-Hazards Preparedness Act.


Our members work to improve health worldwide